ARCHIVES

NCI RFA: Tobacco Use Research Centers

This article is from The Cancer Letter archive.

Vol. 24 No. 48 | December 18, 1998

Download PDF Visit The Full Archive

Related Articles

Groups Urge FDA To Take Action Against Tobacco Products

June 27, 2014

NCI Channels More Money To CIS, 17 Offices Funded

March 9, 1990

Studies of Oncotype DX Test Presented at ASCO Symposium

January 31, 2014

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995

ODAC Okays Photofrin for Obstructive Esophageal Cancer

September 23, 1994

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004